WASHINGTON, Nov. 9, 2017 /Weed Wire/ — On November 9, Americans for Safe Access, filed two requests under the Freedom of Information Act (FOIA) for information on any discussions the Commission had about medical cannabis and specifically the only cannabis study referenced in the President’s Commission on Combating Drug Addiction and the Opioid Crisis draft final report.
Tag Archives: Steph Sherer
PRAGUE, Oct. 16, 2017 /Weed Wire/ — International Cannabis and Cannabinoids Institute (ICCI) welcomes Ethan Russo, MD as the new Director of Research and Development.
WASHINGTON, Sept. 7, 2017 /Weed Wire/ – Last night, the House Committee on Rules voted to not allow a floor vote on an amendment which would continue to prevent the Department of Justice from using funds to interfere with state medical marijuana programs. The amendment, introduced by Representatives Dana Rohrabacher (R-CA) and Earl Blumenauer (D-OR) has been part of the appropriations package since 2015.
WASHINGTON, July 17, 2017 /Weed Wire/ — A meeting scheduled by the President’s Commission on Combating Drug Addiction and the Opioid Crisis for this afternoon has been postponed until July 31, 2017.
WASHINGTON, June 16, 2017 /Weed Wire/ — Today, June 16th, Governor Chris Christie (NJ) will chair the first meeting of the President’s commision on Drug Addiction and Combating Opioid abuse. Americans for Safe Access has submitted comments to the Commission detailing how medical cannabis can be used as a tool in fighting the opioid epidemic.
NASHVILLE, Tenn., June 1, 2017 /Weed Wire/ — Americans for Safe Access (ASA), the nation’s largest patient-focused medical cannabis advocacy organization, is pleased to announce new membership opportunities for medical cannabis patient advocates in Tennessee.
WASHINGTON, March 16, 2017 /Weed Wire/ — Earlier today, Attorney General Jeff Sessions told reporters that “I think medical marijuana has been hyped, maybe too much.”
WASHINGTON, Feb. 13, 2017 /Weed Wire/ — After months of public pressure, the Drug Enforcement Administration (DEA) has removed factually inaccurate information from its website.
WASHINGTON, Dec. 8, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) released a briefing book —“Medical Cannabis in America”— calling on Congress and the Obama Administration to end the conflict between federal and state governments on medical cannabis programs.
WASHINGTON, Dec. 5, 2016 /Weed Wire/ — Americans for Safe Access, a national nonprofit dedicated to ensuring safe and legal access to cannabis for therapeutic use and research, filed a petition with the Department of Justice (DOJ) today demanding that the Drug Enforcement Administration (DEA) immediately update misinformation about cannabis.
WASHINGTON, Sept. 1, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) disseminated a report comparing the body of research the Drug Enforcement Administration (DEA) used as a basis for their decision to keep cannabis (marijuana) as a Schedule I substance.
WASHINGTON, Aug. 9, 2016 /Weed Wire/ — Today, Americans for Safe Access (ASA) released the Medical Cannabis Access for Pain Treatment: A Viable Strategy to Address the Opioid Crisis report to educate legislators and health practitioners on the benefits of medical cannabis as a treatment option for the millions of patients suffering from chronic pain.
NEW YORK, April 28, 2016 /Weed Wire/ — Orrick, a leading global law firm, is partnering with Americans for Safe Access’ (ASA) Patients’ Rights Project to provide pro bono support to medical cannabis patients, many if not most of whom are low-income, to navigate the often confusing legal landscape of medical cannabis laws.
ANNAPOLIS, Md., April 12, 2016 /Weed Wire/ — Yesterday, the Maryland Senate by a vote of 36-10 passed HB104, Medical Cannabis – Written Certifications – Certifying Providers on the last day of the legislative session.
NEW YORK, Feb. 10, 2016 /Weed Wire/ — Today Executive Director of Americans for Safe Access (ASA), Steph Sherer, and Michael Krawitz, Executive Director, Veterans For Medical Cannabis Access will join organizations and patient advocates from across the globe at at the UN Headquarters to continue preparations for the United Nations General Assembly Special Session (UNGASS 2016) on drug policy to be held April 19th-21st.
On Jan. 26, 2016, Americans for Safe Access announced that it had issued its annual report, an analysis of state medical marijuana laws from a patient’s perspective.
On. Oct. 8, 2015, the American Chemical Society’s division of Chemical Health and Safety voted to form the Cannabis Chemistry Subdivision, also known as CANN. The subdivision’s membership will include cannabis specialists in chemistry, research and industry regulations.
A common complaint made by opponents of medical marijuana is that the industry lacks standardization. They say dosage is imprecise, quality varies from plant to plant, safety regulations are insufficient and measurements are ineffective.